Semax vs Dihexa
Which Is Right for You? Complete Comparison (2026)
Semax vs Dihexa comparison — ACTH/MSH analogue that rapidly elevates BDNF for acute cognitive enhancement vs HGF/c-Met activator that promotes dendritic.
Semax vs Dihexa: At a Glance
- ✓Synthetic ACTH(4-10) analogue — heptapeptide nootropic
- ✓Approved in Russia for stroke recovery and cognitive disorders
- ✓Enhances BDNF expression and neuroplasticity
- ✓Neuroprotective against oxidative stress and ischemia
- ✓Administered intranasally — crosses blood-brain barrier
- ✓Stable angiotensin IV analogue — crosses the blood-brain barrier
- ✓Activates HGF/c-Met signaling pathway
- ✓Promotes synaptogenesis and dendritic spine formation
- ✓Reported 10 million-fold more potent than BDNF in cell assays
- ✓Extremely limited human data — primarily animal/in vitro research
Detailed Comparison
| Feature | Semax | Dihexa |
|---|---|---|
| Mechanism | Synthetic ACTH(4-10) analogue | Angiotensin IV analogueBest |
| Dosing | 200-600 mcg intranasally daily | 10-20 mg orally or SC (anecdotal; no established clinical dose) |
| Administration | Intranasal | Oral or subcutaneous |
| Half-life | ~30 seconds plasma; prolonged CNS activity | Extended vs native angiotensin IV (metabolically stabilized) |
| FDA Status | Not FDA-approved (approved in Russia) | Not FDA-approved — research compound |
| Key Trial | Ashmarin IP et al. Neurosci Behav Physiol 2005 — cognitive enhancement | McCoy AT et al. J Pharmacol Exp Ther 2013 — procognitive evaluation |
| Side Effects | Nasal irritation; generally well-tolerated | Unknown in humans; potential oncogenic concern (HGF pathway) |
Which Should You Choose?
Semax (synthetic acth(4-10) analogue) and Dihexa (angiotensin iv analogue) serve different clinical roles despite both being in the Nootropic peptide space. Semax synthetic heptapeptide analogue of acth(4-10) with nootropic and neuroprotective properties. Dihexa metabolically stable angiotensin iv analogue that potently activates hepatocyte growth factor (hgf) signaling and promotes synaptogenesis — 10 million times more potent than bdnf in vitro.
Whichever you choose, track your protocol in Shotlee to build clean data for dose optimization and outcomes comparison.
Making an Informed Choice Between Semax and Dihexa
Choosing between Semax and Dihexa depends on multiple individual factors including your specific health goals, tolerance profile, insurance coverage, and prescriber recommendation. While clinical trial data provides population-level efficacy and safety comparisons, your personal response may differ based on genetics, baseline health, concurrent conditions, and lifestyle factors. Use this comparison as a starting framework and discuss the specifics with your healthcare provider.
Head-to-head clinical trial data between Semax and Dihexa is the gold standard for comparison, but such direct comparisons are not always available for every pair of compounds. Where head-to-head data is lacking, cross-trial comparisons provide useful but imperfect approximations — differences in patient populations, trial design, and endpoint definitions mean that numbers from separate trials are not directly interchangeable. Keep this context in mind when evaluating the comparison data presented here.
Tracking your personal response data in Shotlee is particularly valuable when switching between medications or considering a change. By documenting your outcomes on your current protocol — including efficacy metrics, side effect profile, adherence rate, and quality of life measures — you create an objective baseline for comparison if you transition to the alternative compound. This data transforms a subjective switching decision into an evidence-based protocol optimization.
Semax vs Dihexa: Frequently Asked Questions
Semax is a synthetic acth(4-10) analogue while Dihexa is a angiotensin iv analogue. They differ in mechanism, dosing, and clinical evidence. Your choice should depend on your specific goals and medical history.
Switching should be done under medical supervision. Your prescriber can advise on transition protocols. Track both in Shotlee for comparison data.
Semax works as a synthetic acth(4-10) analogue (200-600 mcg intranasally daily), while Dihexa is a angiotensin iv analogue (10-20 mg orally or SC (anecdotal; no established clinical dose)). They have different half-lives (~30 seconds plasma; prolonged CNS activity vs Extended vs native angiotensin IV (metabolically stabilized)), side effect profiles, and levels of clinical evidence.
Yes. Shotlee supports tracking any medication or peptide. You can compare your results across different protocols.
Neither is universally better — the right choice depends on your individual health profile, treatment goals, side effect tolerance, insurance coverage, and prescriber recommendation. Clinical trial data shows efficacy differences in specific populations, but personal response varies. Track your experience with either medication in Shotlee to generate objective comparison data with your healthcare provider.
Switching between these medications should be done under medical supervision. Your prescriber will consider factors including your current response, reason for switching, dose equivalence, and transition timing. Use Shotlee to document your outcomes on the current medication so you have a clear baseline for comparison after switching.
Track Semax or Dihexa in Shotlee
Free dose tracking, side effect logging, and outcome comparison for any medication protocol.